共 49 条
[4]
BARNETT JA, 2001, CLIN CANCER RES, V13, P3559
[5]
Bauer B, 2004, MOL PHARMACOL, V66, P413
[9]
The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (gleevec): Implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients
[J].
CANCER RESEARCH,
2005, 65 (07)
:2577-2582